Analytics and PsychoPharmacology Laboratory (APPL)
The mission of the Analytics and PsychoPharmacology Laboratory (APPL) is to advance innovative, scientifically rigorous approaches to the understanding, treatment, and prevention of addictions. We accomplish this by:
- Conducting transdisciplinary research in interrelated areas
- Training future scholars and clinicians
- Promoting active participation of program affiliates in relevant policy arenas
Dr. Ekaterina Burduli featured in a King 5 news segment “Washington newborns testing positive for drugs at alarming rates”
Dr. Sterling McPherson invited to speak at John Hopkins University on his research of therapeutics for substance use disorders.
Dr. Andre Miguel and APPL team publish in International Journal of Drug Policy, “Effectiveness of incorporating contingency management into a public treatment program for people who use crack cocaine in Brazil. A single-blind randomized controlled trial”
APPL’s Nikki Akana, Paola Palombo and Abby Bowen represent Community & Behavioral Health at the WSU College of Medicine’s 10-year Anniversary Celebration
APPL is proud to announce three of our Research Coordinators accepted into their programs of choice, taking a huge step in their careers:
Rachel Ryan: Washington State University’s Doctor of Pharmacy program
Nikki Akana: Wayne State University’s Clinical Psychology Doctoral program
Sean Hovland: King’s College London Addictions Master of Science program
Dr. Sterling McPherson recently presented at the Society for the Study of Addiction conference with standing-room-only attendance. Presentation title: Contingency management as a leverageable therapeutic for the treatment of cigarette smoking co-addiction among those with alcohol or stimulant use disorders.
Program of Excellence in Addictions Research
APPL is one of several units housed within the larger Program of Excellence in Addictions Research (PEAR).